TFF Pharmaceuticals TFFP 2022 Investor Presentation

TFF Pharmaceuticals presents its proprietary Thin Film Freezing (TFF) platform technology for converting poorly absorbed drugs into inhalable dry powder formulations. The company has four internal programs in development, including inhalable voriconazole for infections and inhaled tacrolimus for organ transplant rejection, backed by an IP estate of over 120 patents.